Hypha Discovery Ltd

Major Drugs - Uxbridge, ENG, UK

Hypha Discovery Ltd Employees
Frank Scheffler

Head of Business Development & Global Collaborations

Contact Frank Scheffler

Vincent Poon

Recombinant Technologies Group Leader

Contact Vincent Poon

Contact All Hypha Discovery Ltd Employees
Hypha Discovery Ltd Details

Hypha Discovery is a specialist CRO with expertise in scalable synthesis, purification and structure elucidation of phase 1 and phase 2 metabolites using biotransformation and late-stage chemical synthesis techniques. We work with pharma and agrochemical companies globally to make even the most difficult-to-synthesise metabolites. Hypha are experts in purification and structure elucidation of small molecules by NMR spectroscopy, as well as the production of microbial products. Synthesis of metabolites of drugs and agrochemicalsWe create human and other mammalian phase 1 and phase 2 metabolites of drug candidates and agrochemicals at mg to gram scale for many of the top pharma and agrochemical companies. Metabolites produced from a variety of phase I reactions are accessible, including both CYP and non-CYP derived mechanisms in addition to conjugated metabolites such as N-, O– & acyl glucuronides and sulfates. We employ a number of techniques in our One-Stop Metabolite Shop to identify the best method for synthesis and scale-up:• Chemical synthesis • Recombinant enzymes using PolyCYPs and other enzymes• Microbial biotransformation • Mammalian tissues such as liver fractions (S9/microsomes) We can provide an end-to-end service including purification, structure elucidation using NMR spectroscopy, and certificates of analysis.Late stage functionalisationMultiple oxidised derivatives of lead compounds can be accessed in parallel from application of the PolyCYPs enzyme platform and our new late-stage chemical oxidation platform. These techniques generate molecules that have increased polarity together with the possibility of greater activity, better selectivity or improved DMPK properties than the parent compound. The process provides an opportunity for expanding chemical space to generate SAR information or to identify derivatives with superior properties.

Hypha Discovery Ltd logo, Hypha Discovery Ltd contact details
Employees: 20 - 49
HQ:
Location: Uxbridge, ENG, UK
Revenue: 2.5 - 5 Million
Metabolites for DMPK and environmental fate Lead diversification to create oxidised derivatives Contract fermentation purification and structure elucidation Natural product screening libraries Anti-microbial drug screening Late stage hydroxylation CYP metabolites Glucuronides and other conjugated metabolites Non-CYP metabolites Microbial natural products Small molecule purification Structure elucidation chemical synthesis Drug metabolites Environmental fate metabolites Metabolite kits Metabolite purification
Hypha Discovery Ltd Technologies
Email Providers

Outlook

Load Balancers

Nginx

CMS

WordPress.org

Other

Microsoft Office 365

Hosting

Amazon AWS

Email Delivery

Amazon SES

View All Technologies Used At Hypha Discovery Ltd

Contacting Hypha Discovery Ltd: Connect with Executives and Employees

Get in Touch with Hypha Discovery Ltd Executives and Employees

Connecting with Hypha Discovery Ltd's Executives and Workforce

Accessing Contact Information for Hypha Discovery Ltd Executives

Connecting with Hypha Discovery Ltd: Reach Out to Their Team

Discover How to Contact Hypha Discovery Ltd Executives and Staff

Looking to connect with Hypha Discovery Ltd executives or employees?

Seeking to Get in Touch with Hypha Discovery Ltd Executives or Staff?

Want to Reach Out to Hypha Discovery Ltd Executives or Team Members?

In Search of Contact Details for Hypha Discovery Ltd Professionals?

Connecting with Hypha Discovery Ltd: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z